首页 | 本学科首页   官方微博 | 高级检索  
检索        

奥沙利铂联合吉西他滨治疗晚期胰腺癌的临床观察
引用本文:马蕾,柳江.奥沙利铂联合吉西他滨治疗晚期胰腺癌的临床观察[J].临床肿瘤学杂志,2006,11(10):781-782,784.
作者姓名:马蕾  柳江
作者单位:830001,乌鲁木齐,新疆维吾尔自治区人民医院肿瘤内科
摘    要:目的:观察奥沙利铂联合吉西他滨治疗晚期胰腺癌的疗效及不良反应。方法:经影像学诊断的晚期胰腺癌18例,使用奥沙利铂85mg/m2,静脉滴注2小时,第1、8天;吉西他滨835mg/m2,静脉滴注30分钟,第1、8天,21天为1周期,至少用2周期后评价疗效。结果:18例均可评价,获得CR1例,PR3例,总有效率22·2%(4/18)。主要不良反应为骨髓抑制、外周神经毒性及恶心呕吐,无化疗相关死亡。结论:奥沙利铂联合吉西他滨治疗晚期胰腺癌患者疗效较好,不良反应可以耐受,值得深入研究。

关 键 词:胰腺癌  奥沙利铂  吉西他滨
文章编号:1009-0460(2006)10-0781-03
收稿时间:2006-04-01
修稿时间:2006-06-18

Clinical observation of oxaliplatin plus gemcitabine for 18 patients with advanced pancreatic cancer
MA Lei,LIU Jiang.Clinical observation of oxaliplatin plus gemcitabine for 18 patients with advanced pancreatic cancer[J].Chinese Clinical Oncology,2006,11(10):781-782,784.
Authors:MA Lei  LIU Jiang
Abstract:Objective:To evaluate the clinical effect and toxicity of oxaliplatin plus gemcitabine in the treatment of advanced pancreatic cancer.Methods:18 patients with advanced pancreatic cancer diagnosed by imageology were treated with oxaliplatin 85mg/m~2 2 hours iv and gemcitabine 835mg/m~2 30 minutes iv on d1,d8.The regimen was repeated every 21 days and at least two cycles.The evaluation was performed after two cycles. Results:18 patients had evaluative lesions. CR was observed in 1 case and PR in 3 cases,the total response rate was 22.2%(4/18).The main side effects were myelosuppression, neuro-sensory toxicity and nausea/vomiting. There was no any death events during the treatment. Conclusion:oxaliplatin plus gemcitabine in the treatment of advanced pancreatic cancer is effective and tolerable.It is worth studying in future.
Keywords:Pancreatic cancer  Oxaliplatin  Gemcitabine  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号